H. Roché

Randomized 3-arm, phase 2 study of temsirolimus (CCI-779) in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer

J. Carpenter, H. Roché, Mario Campone et al. · Journal of Clinical Oncology · 2005 · 98 citations

Breast Oncology, Pathology, Pharmacotherapy +17

Phase II trial of dasatinib in triple-negative breast cancer: results of study CA180059.

RS Finn, Carmelo Bengala, Nuhad Ibrahim et al. · Cancer Research · 2009 · 70 citations

Breast Oncology, Cancer Management, Pathology +17

SOLTI-0701: A Multinational Double-Blind, Randomized Phase 2b Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo When Administered in Combination with Capecitabine in Patients with Locally Advanced or Metastatic Breast Cancer (BC).

José Baselga, H. Roché, F. Costa et al. · Cancer Research · 2009 · 52 citations

Breast Oncology, Cancer Management, Advanced Bc +17

Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: Results of a double blind multicentre clinical trial

Jacques Bonneterre, L. Mauriac, B. Weber et al. · European Journal of Cancer and Clinical Oncology · 1988 · 46 citations

Advanced Breast Cancer, Breast Oncology, Oncology +9

Clinical pharmacodynamic factors in docetaxel toxicity

Florent Puisset, J. Alexandre, Jean‐Marc Tréluyer et al. · British Journal of Cancer · 2007 · 42 citations · Full text